During the past decade, Sansum Clinic conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 37 clinical trials were completed, i.e. on average, 84.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sansum Clinic" #1 sponsor was "Pfizer" with 8 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sansum Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Sansum Clinic" are "Breast Cancer" (13 trials), "Colorectal Neoplasms" (4 trials), "Ovarian Cancer" (4 trials), "Colorectal Cancer" (3 trials) and "Lymphoma, Non-Hodgkin" (3 trials). Many other conditions were trialed in "Sansum Clinic" in a lesser frequency.

Most popular intervention types in "Sansum Clinic" are "Drug" (70 trials), "Other" (9 trials), "Biological" (5 trials), "Device" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Atezolizumab" (6 trials), "Carboplatin" (5 trials), "Gemcitabine" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Sansum Clinic" are 66 trials for "All" genders, 15 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Sansum Clinic". undefined are not yet recruiting, 8 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Sansum Clinic, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Sansum Clinic, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".

Sansum Clinic has several departments that took part in Clinical trials: "Sansum Clinic Pharm" - 2 trials